Search
for
Sort by
Research 511–540 of 1000+
- Reporting on Adverse Clinical Events
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Teriflunomida and hair disorders
- Drugs that affect autonomic functions or the extrapyramidal system
- Testosterone and female sexuality: A skeptical view
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Intralesional Pentoxifylline Injection Versus Triamcinolone Acetonide in Treating localized Alopecia Areata: A Comparative Study.
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- Alopecia Areata: An Updated Review for 2023
- Stem cell-based therapies for alopecia areata: a narrative review
- Role of oral minoxidil in the treatment of androgenetic alopecia
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- 213P Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial
- Follicular Unit Extraction in Management of Secondary Cicatricial Alopecia
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Autologous adipose tissue injection in the treatment of alopecia: A mini‐review
- The Use of Light‐Based Therapies in the Treatment of Alopecia
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Treatment of alopecia areata affecting both eyebrows: case study
- Primary cicatricial alopecia: diagnosis and treatment
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia
- Cancer-Related Alopecia: From Etiologies to Global Management
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Treatment of Chemotherapy Induced Alopecia
- A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia